Authors: Aladdin, H Larsen, CS Schjerling, P Moller, BK Buhl, MR Gerstoft, J Pedersen, BK Ullum, H

Citation: H. Aladdin et al., Effects of subcutaneous IL-2 therapy on telomere lengths in PBMC in HIV-infected patients, SC J IMMUN, 53(3), 2001, pp. 315-319

Authors: Ellingsen, T Buus, A Moller, BK Stengaard-Pedersen, K

Citation: T. Ellingsen et al., In vitro migration of mononuclear cells towards synovial fluid and plasma from rheumatoid arthritis patients correlates to RANTES synovial fluid levels and to clinical pain parameters, SC J RHEUM, 29(4), 2000, pp. 216-221

Authors: Ellingsen, T Storgaard, M Moller, BK Buus, A Andersen, PL Obel, N Stengaard-Pedersen, K

Citation: T. Ellingsen et al., Migration of mononuclear cells in the modified boyden chamber as evaluatedby DNA quantification and flow cytometry, SC J IMMUN, 52(3), 2000, pp. 257-263

Authors: Aladdin, H Larsen, CS Moller, BK Ullum, H Buhl, MR Gerstoft, J Skinhoj, P Pedersen, BK

Citation: H. Aladdin et al., Effects of subcutaneous interleukin-2 therapy on phenotype and function ofperipheral blood mononuclear cells in human immunodeficiency virus infected patients, SC J IMMUN, 51(2), 2000, pp. 168-175

Authors: Larsen, CS Ostergard, L Moller, BK Buhl, MR

Citation: Cs. Larsen et al., Subcutaneous interleukin-2 in combination with anti-retroviral therapy fortreatment of HIV-1-infected subjects, SC J IN DIS, 32(2), 2000, pp. 153-160